IRIS
DAGNA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.332
NA - Nord America 14.150
AS - Asia 10.437
SA - Sud America 2.226
Continente sconosciuto - Info sul continente non disponibili 887
AF - Africa 235
OC - Oceania 38
AN - Antartide 1
Totale 42.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.216
RU - Federazione Russa 7.050
SG - Singapore 3.623
CN - Cina 3.412
IT - Italia 2.373
BR - Brasile 1.791
RO - Romania 1.151
SE - Svezia 1.137
HK - Hong Kong 1.122
VN - Vietnam 925
DE - Germania 653
FR - Francia 521
CA - Canada 459
GB - Regno Unito 434
BD - Bangladesh 299
IN - India 249
FI - Finlandia 235
AR - Argentina 177
NL - Olanda 160
MX - Messico 154
JP - Giappone 117
AT - Austria 115
PL - Polonia 115
TR - Turchia 101
ID - Indonesia 99
ZA - Sudafrica 95
ES - Italia 91
IQ - Iraq 68
EC - Ecuador 62
CO - Colombia 60
IE - Irlanda 55
PK - Pakistan 54
JM - Giamaica 53
PH - Filippine 51
CR - Costa Rica 48
UA - Ucraina 45
HN - Honduras 41
LT - Lituania 41
MY - Malesia 41
VE - Venezuela 41
MA - Marocco 35
NI - Nicaragua 35
SA - Arabia Saudita 33
GT - Guatemala 31
AE - Emirati Arabi Uniti 29
AU - Australia 29
PY - Paraguay 28
UZ - Uzbekistan 27
PE - Perù 25
BE - Belgio 24
CL - Cile 24
TT - Trinidad e Tobago 24
EG - Egitto 22
IL - Israele 22
NP - Nepal 22
TN - Tunisia 20
IR - Iran 19
KE - Kenya 19
JO - Giordania 18
DO - Repubblica Dominicana 16
SV - El Salvador 16
PR - Porto Rico 14
NO - Norvegia 13
UY - Uruguay 12
AZ - Azerbaigian 11
CH - Svizzera 11
GR - Grecia 11
MD - Moldavia 11
TH - Thailandia 11
DZ - Algeria 10
KZ - Kazakistan 10
PT - Portogallo 10
BG - Bulgaria 9
CW - ???statistics.table.value.countryCode.CW??? 9
GP - Guadalupe 9
KR - Corea 9
BH - Bahrain 8
HU - Ungheria 8
LV - Lettonia 8
NZ - Nuova Zelanda 8
SN - Senegal 8
CZ - Repubblica Ceca 7
EE - Estonia 7
PA - Panama 7
TW - Taiwan 7
XK - ???statistics.table.value.countryCode.XK??? 7
DK - Danimarca 6
BO - Bolivia 5
BW - Botswana 5
EU - Europa 5
GE - Georgia 5
LU - Lussemburgo 5
MK - Macedonia 5
BB - Barbados 4
BS - Bahamas 4
BY - Bielorussia 4
CU - Cuba 4
CY - Cipro 4
ET - Etiopia 4
HT - Haiti 4
Totale 41.351
Salva come PNG Salva come JPEG
Città #
Dallas 2.518
Ashburn 1.826
Singapore 1.794
San Jose 1.453
Moscow 1.399
Hong Kong 1.093
Milan 672
Shanghai 662
Council Bluffs 492
Beijing 489
New York 489
Hefei 436
Lauterbourg 375
Ho Chi Minh City 332
Los Angeles 326
Princeton 289
Lawrence 278
Phoenix 255
Santa Clara 253
Munich 198
Hanoi 197
Boardman 186
São Paulo 182
Rome 155
Nuremberg 152
Helsinki 128
Orem 118
Montreal 110
Denver 103
Atlanta 96
Warsaw 93
Brooklyn 92
London 89
Chicago 82
Tokyo 79
Toronto 79
Miano 75
Guangzhou 70
Poplar 69
Rio de Janeiro 69
Frankfurt am Main 68
Seattle 68
Chennai 63
Houston 62
Boston 61
Johannesburg 61
Mexico City 61
North Bergen 61
Turku 54
Amsterdam 52
Dublin 50
Washington 50
Lappeenranta 49
Stockholm 49
Manchester 47
Naples 45
Pune 43
Ankara 42
Vienna 42
Buffalo 41
Da Nang 41
Mumbai 37
Belo Horizonte 36
San Francisco 35
Brasília 34
San José 34
Falkenstein 33
Haiphong 33
Managua 32
Florence 31
Cesano Boscone 30
Turin 30
Omaha 28
Bologna 27
Tianjin 27
Philadelphia 26
Querétaro 26
The Dalles 26
Charlotte 25
Columbus 25
Istanbul 25
Shenzhen 25
Ancona 24
Curitiba 24
Guatemala City 24
Miami 24
Tashkent 24
Xi'an 24
Bari 23
Brescia 23
Calgary 23
Jakarta 23
Lahore 23
Palermo 23
Bogotá 22
Genoa 22
Kingston 22
New Delhi 22
Campinas 21
Kuala Lumpur 21
Totale 20.000
Salva come PNG Salva come JPEG
Nome #
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 581
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 480
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 460
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 402
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 362
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 360
The association between body mass index and fibromyalgia severity: Data from a cross-sectional survey of 2339 patients 342
Monkeypox in a patient with undifferentiated connective tissue disease 260
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 247
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 246
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 222
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 214
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 211
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 196
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 195
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 192
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 192
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 189
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 188
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 178
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 178
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 169
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 166
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 164
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 162
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 161
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 161
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 160
Biobanking for COVID-19 research 157
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 157
Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy 154
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 154
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 152
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 149
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 148
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 147
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 146
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 145
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 145
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 145
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 144
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 143
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 141
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 141
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 140
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 140
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 138
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 138
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 138
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 137
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 136
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 135
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 134
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 134
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 134
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 133
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 132
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 132
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 132
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 131
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 131
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 130
Therapeutic strategies for primary heart involvement in systemic sclerosis 129
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 128
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 128
Testosterone in males with COVID-19: A twelve-month cohort study 128
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 128
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 128
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 128
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 128
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 127
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 127
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 126
Urgent manifestations of immunoglobulin G4-related disease 125
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 125
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 124
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 124
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 124
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 124
A Novel Histiocytosis With Synovial and Skin Involvement 124
Drug retention rates of biological agents in adult onset Still's disease 124
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 122
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 121
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 121
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 121
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 121
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 121
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 121
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 120
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database 120
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 120
IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans 119
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: A real-life multicentre study 119
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 119
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 119
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 119
C3-glomerulopathy and MGUS: The skin beyond the kidney 118
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 118
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 117
Totale 16.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022327 0 0 0 78 26 27 33 26 42 37 30 28
2022/20232.175 652 435 141 21 36 244 220 209 102 39 40 36
2023/20242.244 79 135 231 200 184 373 118 204 18 92 210 400
2024/20257.670 639 146 220 243 291 550 2.019 711 1.014 686 486 665
2025/202624.010 1.583 2.171 2.331 2.866 1.780 662 2.025 1.662 6.132 1.253 731 814
2026/20275.548 733 1.285 1.298 2.232 0 0 0 0 0 0 0 0
Totale 42.306